A Study to Evaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: Epithelial Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer Interventions: Drug: KAND567; Drug: Carboplatin Sponsors: Kancera AB; Nordic Society of Gynaecological Oncology - Clinical Trials Unit Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Clinical Trials | Epithelial Cancer | Fallopian Tube Cancer | OBGYN | Ovarian Cancer | Ovaries | Peritoneal Cancer | Research | Study | Women